Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer

Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer

BackgroundBladder cancer is the 10th most common cancer and most common urothelial malignancy worldwide. Prognostic biomarkers for bladder cancer patients are required for individualized treatment. Monocarboxylate transporter 4 (MCT4), encoded by SLC16A3 gene, is a potential biomarker for bladder ca...

Full description

Bibliographic Details
Main Authors: Yang Zhao, Bin Zhao, Wei-Hua Yan, Yan Xia, Zhi-Hui Wang, Guo-Yang Zheng, Wen-Da Wang, Yu-Shi Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
bladder cancer
monocarboxylate transporter 4
solute carrier family 16 member 3
single-cell RNA sequencing
immunohistochemistry
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.704857/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.704857/full

Similar Items